This study is looking at how Sculptra Aesthetic, a treatment for skin laxity, works on the abdomen of women. Researchers want to see if Sculptra helps improve loose skin in women who are taking GLP-1 agonist medications (used for conditions like diabetes or weight management), compared to women who are not on these medications. You might be able to join if you are a woman between 25 and 65 years old with mild to moderate loose skin on your abdomen, a stable weight, and a BMI of 27 or less. If you are on a GLP-1 medication, you must have been on a stable dose for at least 6 months. The main goal is to see how much the skin improves after 3 and 9 months. The current status of this study is unclear, and it plans to enroll 20 participants.

Study design

This is an interventional study involving 20 women, with 15 taking GLP-1 medication and 5 not. All participants will receive Sculptra Aesthetic.

What's involved

Participants will receive three treatments of Sculptra Aesthetic to the abdomen, one month apart. You will also have follow-up visits at month 3 and month 9 for photography and assessments.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for 9 months after their initial treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.